Clinical trial

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

NCT00093795

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhasePHASE3

Study timeline

Study start (unknown)2004-10-01Date precision: month

Registry last updated2018-01-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

DocetaxelDRUG · verified · RxNorm: docetaxel

GemcitabineDRUG · verified · RxNorm: gemcitabine

PaclitaxelDRUG · verified · RxNorm: paclitaxel

DoxorubicinDRUG · verified · RxNorm: doxorubicin

Sponsors & collaborators

NSABP Foundation Inclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

PhiladelphiaPennsylvania, United States1 BirminghamAlabama, United States1 OmahaNebraska, United States1 CharlotteNorth Carolina, United States1 LexingtonKentucky, United States1 TacomaWashington, United States1 HackensackNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00093795 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.